COMPANY

Silo Pharma

Keywords: neurology post-traumatic stress disorder fibromyalgia chronic pain psychiatry

Location: Sarasota, FL · source · Oct 2, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $4M (Form D filed Jul 14, 2026). SEC Form D 0001213900-26-077974 (Jul 14, 2026)
Evidence (1 event)
- Jul 14, 2026 · SEC Form D 0001213900-26-077974
  Name of Issuer: Silo Pharma, Inc.; CIK: 1514183; Address: Sarasota, FL; Submission type: D; Filing date: 2026-07-14; Industry Group: Pharmaceuticals; Date of First Sale: 2026-07-09; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 4000015; Total Amount Sold: 4000015; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

May 16, 2025 Raise Follow-on offering: $2M (total, as published), announced May 16, 2025. Source: company release on GlobeNewswire. source ↗

Raised: $2.0M. Last 2 years.

May 16, 2025 Follow-on offering: $2M (total, as published), announced May 16, 2025. Source: company release on GlobeNewswire. source ↗

Form D raises come from the company’s own SEC filing (last 2 years).

2026-07-14 Raise Private raise (SEC Form D): $4.0M sold; issuer “Silo Pharma, Inc.”. Verified from the SEC filing. SEC filing ↗